Structural mimicry of UM171 and neomorphic cancer mutants co-opts E3 ligase KBTBD4 for HDAC1/2 recruitment
Zhuoyao Chen, Gamma Chi, Timea Baló, Xiangrong Chen, Beatriz Ralsi Montes, Steven C. Clifford, Vincenzo D’Angiolella, Tímea Szabó, Arpad Kiss, Tibor Novák, András Herner, András Kotschy, Alex N. Bullock
The paper identifies how neomorphic KBTBD4 mutations and the drug UM171 recruit HDAC1/2 complexes through structural mimicry, revealing a common mechanism for their degradation.
Nature Communications · Apr 2, 2025Peer-reviewedMolecular Biology